Page 276 | ASweetLife

Sanofi-aventis and Columbia University to Collaborate on Diabetes Research

Sanofi-aventis and Columbia University Medical Center announced a three-year research collaboration for the development of innovative diabetes medicines. This research collaboration, with the laboratory of Dr. Gerard Karsenty, will investigate the role of the osteoblast-secreted peptide, osteocalcin, in diabetes management...

A Low Glycemic Index Diet for Diabetes

My diet is actually high in carbs -- oatmeal, beans and lots of non-starchy vegetables...

Novo Nordisk Campaign Urges Diabetes Patients to Use Prefilled Insulin Pens

Novo Nordisk is partnering with 2011 IZOD IndyCar Series driver Charlie Kimball to launch the educational program, Drive the Switch, encouraging diabetes patients who use insulin and caregivers to pledge to talk to their healthcare professional about options for insulin delivery, like the prefilled insulin pen device...

Levemir Better for Treating Young Children with Type 1 Diabetes Than Human Basal Insulin

New clinical trial data just published in Pediatric Diabetes shows that Levemir (insulin detemir), Novo Nordisk’s basal insulin analogue, is an equally efficacious treatment option for two to five year-old children with type 1 diabetes, compared with human basal insulin, but is associated with lower hypoglycemic risk. Children with type 1 diabetes who are aged under six years...

XOMA Type 2 Diabetes Drug Fails to Meet End Point in Phase 2 Trials

XOMA Ltd. announced that its phase 2b trial of XOMA 052 in type 2 diabetes patients did not achieve the primary endpoint of reduction of HbA1c after six monthly treatments with XOMA 052 compared to placebo. Biological activity of XOMA 052 supporting its potential...